使用蛋白质组测量方法,提前检测药物效益和不良影响
Jessica Chadwick1, Colin Berry2, Meredith A Carpenter1
1Standard BioTools, South San Francisco, CA, USA.
Journal of clinical pharmacology
|July 6, 2025
概括
蛋白质组学可以在临床试验的早期确定药物益处和风险,可能减少参与者数量和试验持续时间. 这种方法有助于优化新疗法药物开发管道.
科学领域:
- 生物化学和药理学 生物化学和药理学
- 临床试验优化 临床试验优化
- 蛋白质组学是指蛋白质组学.
背景情况:
- 在临床试验中早期识别治疗益处和不良影响对于提高安全性,效率和成本效益至关重要.
- 对心脏代谢结果的蛋白质组测量已在检测药物效应方面显示出有前途.
研究的目的:
- 调查是否验证的蛋白质组测量可以在较少的参与者中检测出有益和有害的药物效应,并在各种临床试验中缩短后续期.
- 评估蛋白质组学在优化药物开发管道中的实用性.
主要方法:
- 在四个不同的临床试验中进行的SomaSignal蛋白质组测试的分析:EXSCEL (exenatide),SUGAR-DM-HF (empagliflozin),AMPLE (abatacept,adalimumab) 和PRADA (epirubicin).
- 评估随着时间的推移对各种药物类别和疾病的反应中的蛋白质组变化.
- 蛋白质检测效应与原始研究参数的比较.
主要成果:
- 埃克西纳提德在1年内显示出心血管风险和心脏代谢改善,可检测到更小的样本大小.
- 在一个小队列中,empagliflozin在36周内表现出心脏和脏保护作用.
- 在85天内,阿巴塔塞普和阿达利姆巴显著改善了心血管风险和心肺呼吸能力.
- 埃皮鲁比 (人环素) 增加了心力衰竭死亡风险和一个化疗周期后心血管风险.
结论:
- 蛋白质组学为预测治疗效果提供了一个强大的工具,可以在更小,更短的临床试验中检测好处和风险.
- 这种方法可以通过提供对药物的有效性和安全性的早期见解,显著优化药物管道.
- 蛋白质组分析有助于制定更高效,更具成本效益的药物开发策略.
更多相关视频
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
17.2K
13:00Low Molecular Weight Protein Enrichment on Mesoporous Silica Thin Films for Biomarker Discovery
Published on: April 17, 2012
13.6K
相关概念视频
Proteomics
8.0K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
8.0K
Protein-Drug Binding: Determination Methods
316
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
316
Pharmacovigilance
999
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
999
Drug Discovery: Overview
8.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.8K
